Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned.
about
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseasesPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3Genome-wide interaction study of smoking and bladder cancer riskA multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociReview of the Gene-Environment Interaction Literature in Cancer: What Do We Know?A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisCommon genetic variants in the PSCA gene influence gene expression and bladder cancer riskRecommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans.Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.Update on the pharmacogenetics of NATs: structural considerations.Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
P2860
Q24289213-D82B6F07-E691-4589-962E-ECE1F29F283FQ27011622-C3C460B7-18EC-4FAD-8637-7E6DB3A24CE2Q28943348-7D257999-5FE2-439C-8FD4-54E8A013FEAEQ28943359-AEC793A4-2E49-433F-8194-DB9D370B5F6EQ28943367-6D3A4683-0FC0-479E-AC01-CB8A315B0A2EQ30251624-46FC2D70-A3E0-4CB3-8652-A0F028AC1BEFQ34414220-8FBAC114-1D45-412A-816F-995D0B2C68E8Q34520370-D604D9DE-A799-4860-BFCF-A9F08783ACA6Q35882541-38D20404-C2E5-4744-BA03-EFF9FB087414Q36349558-E51D11D6-7C3D-4FFE-9401-30786C3667F2Q36916852-38E659CB-16E8-452C-B787-5D42FF4B8E08Q37329162-8D3F853F-8B8B-48F5-856D-537530CFB6FDQ37457764-0E13907A-33C6-43E4-AC9B-964D80508961Q38684214-71A9FFA3-4AD3-4C8F-BAF2-85805DF433D5Q47359205-19481FD7-B121-443D-8878-2EB65F95CACC
P2860
Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Commentary: Reflections on G. ...... pothesis, and lessons learned.
@en
type
label
Commentary: Reflections on G. ...... pothesis, and lessons learned.
@en
prefLabel
Commentary: Reflections on G. ...... pothesis, and lessons learned.
@en
P2860
P50
P356
P1476
Commentary: Reflections on G. ...... pothesis, and lessons learned.
@en
P2860
P356
10.1093/IJE/DYM026
P577
2007-02-01T00:00:00Z